<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03195244</url>
  </required_header>
  <id_info>
    <org_study_id>AT&amp;ASD</org_study_id>
    <nct_id>NCT03195244</nct_id>
  </id_info>
  <brief_title>Aquatic Therapy and Autism Spectrum Disorders</brief_title>
  <acronym>AT&amp;ASD</acronym>
  <official_title>Aquatic Therapy and Autism Spectrum Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sloan W. Rush, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Panhandle Eye Group, LLP</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the efficacy of one-on-one versus group-based aquatic therapy on the social&#xD;
      interactions, behaviors and physical activities of children with autism spectrum disorders&#xD;
      (ASDs).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 12, 2017</start_date>
  <completion_date type="Anticipated">February 12, 2023</completion_date>
  <primary_completion_date type="Anticipated">February 12, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in PedsQL Score</measure>
    <time_frame>Baseline and 10 weeks after intervention</time_frame>
    <description>Survey</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Autism Spectrum Disorder</condition>
  <arm_group>
    <arm_group_label>Observation</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>One-on-one Aquatic Therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Group Aquatic Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Aquatic Physical Therapy</intervention_name>
    <description>Swim Whisperer's Aquatic Therapy Sessions</description>
    <arm_group_label>Group Aquatic Therapy</arm_group_label>
    <arm_group_label>One-on-one Aquatic Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Eligibility criteria:&#xD;
&#xD;
          -  DSM-V diagnosis of Autism Spectrum Disorder or DSM-IV diagnosis of Asperger's syndrome&#xD;
             or high functioning atypical autism or pervasive development disorder - not otherwise&#xD;
             specified or else the typical clinical findings and suspicion of an ASD&#xD;
&#xD;
          -  Treatment na√Øve to prior aquatic therapy&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Not willing to undergo an investigational treatment&#xD;
&#xD;
          -  Unable to cooperate well enough to safely participate in aquatic therapy under the&#xD;
             protocol guidelines&#xD;
&#xD;
          -  Known allergies to pool chemicals&#xD;
&#xD;
          -  Other significant co-morbidities which may include (but is not limited to): severe&#xD;
             cerebral palsy with low motor function, advanced pulmonary disease, home oxygen&#xD;
             requirement, spina bifida with low motor function, permanent feeding tubes, poorly&#xD;
             controlled seizure disorder, chronic indwelling urinary catheters or any condition&#xD;
             causing severe cognitive impairment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Bruce Moseley</last_name>
    <phone>806-353-3596</phone>
    <email>bruce@turncenter.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Turn Center</name>
      <address>
        <city>Amarillo</city>
        <state>Texas</state>
        <zip>79106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruce Moseley</last_name>
      <phone>806-353-3596</phone>
      <email>bruce@turncenter.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>June 12, 2017</study_first_submitted>
  <study_first_submitted_qc>June 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 22, 2017</study_first_posted>
  <last_update_submitted>March 8, 2021</last_update_submitted>
  <last_update_submitted_qc>March 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Panhandle Eye Group, LLP</investigator_affiliation>
    <investigator_full_name>Sloan W. Rush, MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>aquatic therapy, hydrotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Autistic Disorder</mesh_term>
    <mesh_term>Autism Spectrum Disorder</mesh_term>
    <mesh_term>Child Development Disorders, Pervasive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

